In this Issue:
MicroRNA expression profile in UC
Adalimumab and infliximab levels in neonates
Cross-immunogenicity to infliximab biosimilars
Antibodies to infliximab during induction in UC
Psoriasis in IBD patients treated with anti-TNF alpha
Vedolizumab, corticosteroids and immunosuppressants
Adenomatous polyps in UC
Long-term efficacy of vedolizumab therapy for CD
Long-term efficacy of vedolizumab therapy for UC
Fetal risks in pregnancy before and after IBD diagnosis
Please login below to download this issue (PDF)